|
AU2003290333A1
(en)
*
|
2002-12-24 |
2004-07-22 |
Biofocus Plc |
Compound libraries of imidazo(1,5-a)pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
|
|
WO2005021545A1
(en)
|
2003-09-03 |
2005-03-10 |
Galapagos Nv |
IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
|
|
WO2008022060A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Novartis Ag |
Imidazo-pyridine derivatives for modulating protein kinase activity
|
|
EP2529621B1
(en)
*
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
EP2139487B1
(en)
|
2007-03-28 |
2015-11-11 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
ES2396613T3
(es)
|
2008-05-19 |
2013-02-22 |
OSI Pharmaceuticals, LLC |
Imidazopirazinas e imidazotriazinas sustituidas
|
|
US8658794B2
(en)
|
2010-02-08 |
2014-02-25 |
Merck Sharp & Dohme B.V. |
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof
|
|
JP2014509616A
(ja)
|
2011-03-31 |
2014-04-21 |
エーエムベーエルエーエム テクノロジー トランスファー ゲーエムベーハー |
治療用イミダゾ［１，２−ａ］ピリジン化合物
|
|
GB2513821A
(en)
*
|
2011-06-28 |
2014-11-12 |
Andrew Levine |
Speech-to-text conversion
|
|
EP2548877A1
(en)
*
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
CN103889987B
(zh)
|
2011-07-19 |
2016-09-14 |
默沙东有限责任公司 |
作为btk抑制剂的选择的咪唑并吡嗪类
|
|
WO2013010869A1
(en)
*
|
2011-07-19 |
2013-01-24 |
Msd Oss B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
|
|
FR2985185B1
(fr)
*
|
2012-01-04 |
2013-12-27 |
Sanofi Sa |
Utilisation en therapeutique de derives d'imidazopyridine
|
|
EP2809673B1
(en)
|
2012-01-31 |
2016-11-02 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as bruton's tyrosine kinase inhibitors
|
|
US9481682B2
(en)
*
|
2013-01-23 |
2016-11-01 |
Merck Sharp & Dohme Corp. |
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
|
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
JP2016533385A
(ja)
*
|
2013-08-22 |
2016-10-27 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
アルキニルアルコール及び使用方法
|
|
WO2015057992A1
(en)
*
|
2013-10-16 |
2015-04-23 |
Izumi Raquel |
Btk inhibitors for hematopoietic mobilization
|
|
WO2015157955A1
(en)
|
2014-04-17 |
2015-10-22 |
Abbvie Inc. |
Heterocyclic btk inhibit ors
|
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
|
WO2016106626A1
(en)
*
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
|
MA41614A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Alios Biopharma Inc |
Composés antiviraux
|
|
US20180305350A1
(en)
*
|
2015-06-24 |
2018-10-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
US20190008859A1
(en)
*
|
2015-08-21 |
2019-01-10 |
Acerta Pharma B.V. |
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
|
|
CN106478633A
(zh)
*
|
2015-08-27 |
2017-03-08 |
正大天晴药业集团股份有限公司 |
一类布鲁顿酪氨酸激酶抑制剂
|
|
US20170071962A1
(en)
|
2015-09-11 |
2017-03-16 |
Acerta Pharma B.V. |
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
|
|
US20170035881A1
(en)
*
|
2015-10-19 |
2017-02-09 |
Acerta Pharma B.V. |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
|
|
WO2017077507A1
(en)
*
|
2015-11-06 |
2017-05-11 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of bruton's tyrosine kinase
|
|
EP3426637B1
(en)
|
2016-03-11 |
2022-02-09 |
Angel Pharmaceutical Co., Ltd. |
Compounds and methods for modulating bruton's tyrosine kinase
|
|
US10640512B2
(en)
|
2016-06-30 |
2020-05-05 |
Hangzhou Sanyintai Pharmaceutical Technology Co., Ltd. |
Imidazopyrazinamine phenyl derivative and use thereof
|
|
CN109851620B
(zh)
*
|
2016-08-17 |
2020-08-07 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制酪氨酸激酶活性的稠合双环类化合物
|
|
US11554118B2
(en)
*
|
2017-03-22 |
2023-01-17 |
Xibin Liao |
Bruton's tyrosine kinase inhibitors
|